Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 18Other hematologic neoplasm 14CNS 8Plasma cell 6Genitourinary 4Sarcoma 3Dermatologic 2Tumor-Agnostic 1Thoracic 1Myeloid 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Melanoma 2

Interventions

pembrolizumab 100Nivolumab 69Cyclophosphamide 67Ipilimumab 66fludarabine 34aldesleukin 29fludarabine phosphate 28Vemurafenib 28Interleukin-2 26trametinib 20Biopsy 20dabrafenib 17Radiotherapy 16Temozolomide 15Cisplatin 15Magnetic Resonance Spectroscopy 14Gemcitabine 14Filgrastim 14atezolizumab 13Specimen Handling 13Carboplatin 13CTLA-4 Antigen 13spartalizumab 12romidepsin 12Paclitaxel 12Bortezomib 11poly ICLC 10cobimetinib 10Peripheral Blood Stem Cell Transplantation 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Leukapheresis × Dermatologic × Clear all
NCT00005617 2020-08-03

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

Jonsson Comprehensive Cancer Center

Phase 1 Completed
Dermatologic

Melanoma

NCT01783431 2015-10-02

Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells

Medical University of South Carolina

Phase 1 Terminated
1 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡